![John Orloff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Orloff
No open positions remaining
Net worth: - $ as of 30/05/2026
Profile
Presently, John J. Orloff is Executive VP, Head-Research & Development at Alexion Pharmaceuticals, Inc. In the past he held the position of Director at Novelion Therapeutics, Inc., Executive Vice President & Head-Research at Aegerion Pharmaceuticals, Inc., Chief Scientific Officer, EVP, Global Head-R&D at Baxalta, Inc., Vice President, Global Head-Research & Development at Baxter BioScience Corp. and Chief Medical Officer & Senior Vice President of Novartis Pharma AG. Dr. Orloff received an undergraduate degree from Dartmouth College and a doctorate from the University of Vermont College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 14/06/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
John Orloff active positions
| Companies | Position | Start |
|---|---|---|
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Private Equity Investor | 30/09/2021 |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Director/Board Member | - |
Former positions of John Orloff
| Companies | Position | End |
|---|---|---|
| BENEVOLENTAI S.A. | Director/Board Member | 15/10/2024 |
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Director/Board Member | 30/09/2024 |
| ALEXION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 20/07/2021 |
| NOVELION THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 30/06/2017 |
| BAXALTA INC | Chief Tech/Sci/R&D Officer | 31/05/2016 |
Training of John Orloff
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
University of Vermont College of Medicine
 University of Vermont College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
BenevolentAI Ltd.
BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Technology Services |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
Zenas Pharma, Inc.
Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Health Technology |
- Stock Market
- Insiders
- John Orloff
